New and Noteworthy | Flatiron Health

Showing 9 of 0 results

Evaluating transportability of overall survival estimates from US to UK populations receiving first-line treatment for advanced non-small cell lung cancer: a retrospective cohort study
BMJ Open
Real-world demographics, clinical characteristics, and treatment patterns among US patients with HER2-negative early breast cancer and germline BRCA mutations since 2021
San Antonio Breast Cancer Symposium
Clinical characteristics and treatment persistence in US patients with HR+/HER2-, node positive early breast cancer treated with abemaciclib: Real-world study from first year after approval
San Antonio Breast Cancer Symposium
Tolerability of first-line treatment with ribociclib for metastatic breast cancer using two large US data sources
San Antonio Breast Cancer Symposium
Comparative overall survival of CDK4/6is plus an aromatase inhibitor in HR+/HER2- metastatic breast cancer in the US real-world setting
San Antonio Breast Cancer Symposium
A real-world analysis of the relationship between Epstein-Barr Virus positivity and baseline characteristics, treatment patterns and clinical outcomes in diffuse large B-cell lymphoma
ASH Annual Meeting
Design and methodological considerations for real-world data-derived progression-free survival in Multiple Myeloma
ASH Annual Meeting
The impact of structural racism and social determinants of health on fluorescence in situ hybridization testing among patients with multiple myeloma
ASH Annual Meeting
- Publication summary
- Publications
Real-world characteristics and survival outcomes of patients with Mantle Cell Lymphoma treated with covalent Bruton's tyrosine kinase inhibitors in first-line
ASH Annual Meeting
- Publication summary
- Publications

Publication summary